A European multicentre drug utilisation study of the impact of regulatory measures on prescribing of codeine for pain in children-Reference-Cited by-同舟云学术

A European multicentre drug utilisation study of the impact of regulatory measures on prescribing of codeine for pain in children

Published:2019-06-20 Issue:8 Volume:28 Page:1086-1096
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Hedenmalm Karin¹^ORCID,Blake Kevin²,Donegan Katherine³,Macia Miguel‐Angel⁴,Gil Miguel⁴,Williams Julie⁵,Montero Dolores⁴⁶,Candore Gianmario¹,Morales Daniel⁷,Kurz Xavier⁷^ORCID,Arlett Peter⁷

Affiliation:

1. Business, Data and Analytics DepartmentEuropean Medicines Agency London UK

2. Specialised Scientific Disciplines DepartmentEuropean Medicines Agency London UK

3. Vigilance and Risk Management of MedicinesMedicines and Healthcare Products Regulatory Agency London UK

4. Division of Pharmacoepidemiology and PharmacovigilanceSpanish Agency for Medicines and Medical Devices Madrid Spain

5. Pharmacovigilance and Risk Management PlanningMedicines and Healthcare Products Regulatory Agency London UK

6. Spanish Medicines & Medical Devices Agency (Agencia Española de Medicamentos y Productos Sanitarios) Madrid Spain

7. Pharmacovigilance and Epidemiology DepartmentEuropean Medicines Agency London UK

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.4836

Reference56 articles.

1. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity

2. World Health Organization.Unedited report of the 18th Expert Committee on the Selection and Use of Essential Medicines. Geneva Switzerland;2011.

3. World Health Organisation.WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses Geneva Switzerland;2012Contract No.: ISBN 978 92 4 154812 0

4. FDA Drug Safety Communication.Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare but life‐threatening adverse events or death:thasso.com;2014[Available from:http://thasso.com/fda‐drug‐safety‐communication‐codeine‐use‐in‐certain‐children‐after‐tonsillectomy‐andor‐adenoidectomy‐may‐lead‐to‐rare‐but‐life‐threatening‐adverse‐events‐or‐death/.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Limitations Reported in Evaluating Effectiveness of Risk Minimization Measures in the EU during 2018–2021: A Qualitative Analysis of Industry‐Sponsored Post‐Authorization Safety Studies;Clinical Pharmacology & Therapeutics;2024-07-12

2. Commercializing Personal Health Information: A Critical Qualitative Content Analysis of Documents Describing Proprietary Primary Care Databases in Canada;International Journal of Health Policy and Management;2023-04-04

3. Prescribing Patterns of Codeine and Alternative Medicines in Children in Europe;Drug Safety;2022-08-24

4. International perioperative pain management approaches;Opioid Use, Overuse, and Abuse in Otolaryngology;2022

5. Opioid Analgesic Prescription in French Children: A National Population-Based Study;International Journal of Environmental Research and Public Health;2021-12-17